story of the week
Circulating Tumor DNA Minimal Residual Disease as a Biomarker of NSCLC Outcomes
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Journal of Clinical Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Circulating Tumor DNA Minimal Residual Disease Detection of Non-Small-Cell Lung Cancer Treated With Curative Intent
J. Clin. Oncol 2022 Jan 05;[EPub Ahead of Print], B Pellini, AA ChaudhuriFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.